4//SEC Filing
Longevity Fund 2 LP 4
Accession 0001209191-21-012000
CIK 0001656536other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 5:40 PM ET
Size
7.1 KB
Accession
0001209191-21-012000
Insider Transaction Report
Form 4
Longevity Fund 2 LP
10% Owner
Transactions
- Conversion
Common Stock
2021-02-17+79,143→ 79,143 total - Conversion
Convertible Series C Preferred Stock
2021-02-17−79,143→ 0 total→ Common Stock (79,143 underlying)
Footnotes (1)
- [F1]The Convertible Series C Preferred Stock converted into the issuer's common stock on a 12.6352-for-one basis upon the filing of the issuer's Restated Certificate of Incorporation in connection with the closing of the initial public offering and had no expiration date.
Documents
Issuer
Decibel Therapeutics, Inc.
CIK 0001656536
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001708655
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 5:40 PM ET
- Size
- 7.1 KB